|
|
|
|
|
Inactive Indication- |
Drug Highest PhaseClinical |
First Approval Ctry. / Loc.- |
First Approval Date20 Jan 1800 |
100 Clinical Results associated with MAdCAM-1 x VEGFR2 x CD14
100 Translational Medicine associated with MAdCAM-1 x VEGFR2 x CD14
0 Patents (Medical) associated with MAdCAM-1 x VEGFR2 x CD14